Wpp TURINABOL 10mg

Description

Wpp Turinabol 10mg represents a specific formulation of turinabol, a synthetic oral anabolic-androgenic steroid (AAS). Its chemical name is 4-chloro-17α-methyl-17β-hydroxy-1,4-androstadien-3-one, and it carries the CAS number 855-19-6. Turinabol is a derivative of methandrostenolone (Dianabol), but a chlorine atom at the 4th position of the molecule modifies its activity. This structural modification makes the compound a milder anabolic agent. Unlike Dianabol, turinabol does not aromatize, meaning the body cannot convert it into estrogen. Consequently, researchers often classify it as a “mild” steroid.

---

Historical Background and Notoriety

Turinabol gained significant historical notoriety during the 1970s and 1980s. It was a central component of the East German state-sponsored doping program. Coaches and officials administered the drug to thousands of young athletes, often without their knowledge. Athletes were frequently told they were receiving vitamins. The program aimed to enhance athletic performance at the Olympic Games. Many athletes suffered devastating health consequences later, including liver damage, sterility, and hormonal imbalances. This dark chapter in sports history has made turinabol a symbol of systemic doping.

---

Mechanism of Action and Research Applications

Turinabol exerts its primary effects through binding to and activating the androgen receptor (AR). It has a predominantly anabolic effect while exhibiting relatively weak androgenic activity. Specifically, its anabolic effect is approximately 53% that of testosterone, while its androgenic effect is only about 6%. This ratio makes it attractive for research applications seeking to minimize androgenic side effects like hair loss or prostate stimulation.

Researchers have explored the compound for several therapeutic applications:

• Bone Health and Osteoporosis: The drug promotes calcium deposition in bones, potentially benefiting conditions like osteoporosis due to androgen deficiency in hypogonadal males.

• Muscle Wasting and Anemia: Studies have indicated its use for conditions involving negative nitrogen balance, including cachexia, extensive burns, trauma, and certain anemias.

• Endurance Performance: Because it does not cause significant water retention, it has been researched for endurance sports and speed disciplines.

---

Critical Safety Concerns and Toxicity

Despite its research potential, Wpp Turinabol 10mg carries significant and well-documented safety risks. As a 17α-alkylated oral steroid, it is associated with substantial hepatotoxicity.

Hepatotoxicity: This is the most serious concern with turinabol. It can cause cholestatic jaundice, liver cell necrosis, and elevated levels of bilirubin and transaminases. The risk increases with higher doses and longer cycles, and cases of liver tumors have been reported after extended use. It is critical to monitor liver function carefully during any research involving this compound.

Endocrine Disruption: Although it has mild androgenic effects, turinabol still suppresses the hypothalamic-pituitary-gonadal (HPG) axis. This leads to inhibition of natural testosterone production and can impair spermatogenesis.

Other Adverse Effects: These may include negative impacts on cholesterol levels, such as lowering HDL (“good cholesterol”) and raising LDL (“bad cholesterol”). In rare cases, androgenic side effects like acne and body hair growth may occur.

---

Regulatory Status and Prohibition

Wpp Turinabol 10mg is a strictly controlled substance in most countries. The World Anti-Doping Agency (WADA) lists turinabol on its Prohibited List as an Anabolic Agent, and its use in athletic competition is strictly forbidden. It is available only for research purposes in controlled laboratory settings or as an export-only product.

---

Conclusion

In summary, Wpp Turinabol 10mg is a research compound with a unique history and a well-characterized mechanism of action. It offers moderate anabolic effects with lower androgenic activity compared to some other steroids. However, its significant potential for hepatotoxicity, endocrine disruption, and WADA-prohibited status make it a high-risk substance. Researchers must treat it with extreme caution and adhere strictly to safety protocols.

---

Internal Links (Hypothetical for a research chemical website):

• /products/wpp-turinabol-10mg/: View our research-grade Turinabol.

• /research-education/anabolic-steroids-guide/: Learn about the science of anabolic steroids.

• /research-education/liver-toxicity-research/: Explore research on hepatotoxicity in AAS.

• /blog/androgen-receptor-pathway/: Deep dive into androgen receptor signaling.

• /faq/research-compounds/: Frequently asked questions about research compounds.

External Links:

• MeSH (Turinabol Supplementary Concept): https://www.ncbi.nlm.nih.gov/mesh/67041029

• PubChem (Turinabol Information): https://pubchem.ncbi.nlm.nih.gov/compound/855-19-6

• IUCr Journal (Crystal Structure of Turinabol): https://journals.iucr.org/paper?vp3023

• PubMed (Metabolic Studies in Horses): https://pubmed.ncbi.nlm.nih.gov/17386713/

• WADA Prohibited List: https://www.wada-ama.org/en/prohibited-list